Literature DB >> 324638

The production of heterologous antibodies to the human lymphakine: leukocyte migration inhibitory factor (LIF).

K Bendtzen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324638     DOI: 10.1016/0008-8749(77)90333-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

1.  Lymphocyte chemotaxis in inflammation. VIII. Demonstration of lymphocyte chemotactic lymphokines in PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.

Authors:  Y Shimokawa; S Harita; Y Mibu; H Hayashi
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

2.  Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.

Authors:  A Kijlstra; L Broersma
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

3.  Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis.

Authors:  K Bendtzen; J Petersen; J Halkjaer-Kristensen; T Ingemann-Hansen
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

4.  Severe acquired immunodeficiency in European homosexual men.

Authors:  J Gerstoft; A Malchow-Møller; I Bygbjerg; E Dickmeiss; C Enk; P Halberg; S Haahr; M Jacobsen; K Jensen; J Mejer; J O Nielsen; H K Thomsen; J Søndergaard; I Lorenzen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

5.  Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A.

Authors:  J Palit; K Bendtzen; V Andersen
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

6.  Human migration inhibitory factor: purification and immunochemical characterization.

Authors:  L H Block; H Jaksche; S Bamberger; G Ruhenstroth-Bauer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.